Download FREE Report Sample
Download Free sampleAcemetacin is a carboxylic ester that is the carboxymethyl ester of indometacin. A non-steroidal anti-inflammatory drug, it is used in the treatment of rheumatoid arthritis, osteoarthritis, and low back pain, as well as for postoperative pain and inflammation.
Acemetacin Market contains market size and forecasts of Acemetacin (CAS 53164-05-9) in global, including the following market information:
Global Acemetacin (CAS 53164-05-9) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Acemetacin (CAS 53164-05-9) Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Acemetacin (CAS 53164-05-9) companies in 2021 (%)
The global Acemetacin (CAS 53164-05-9) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
98% Purity Type Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Acemetacin (CAS 53164-05-9) include 3B Scientific, CSPC, DC Chemicals, OChem, Adooq BioScience, Clearsynth, Angene Chemical, Vlada Chem and AbMole Bioscience, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Acemetacin (CAS 53164-05-9) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Acemetacin (CAS 53164-05-9) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Acemetacin (CAS 53164-05-9) Market Segment Percentages, by Type, 2021 (%)
98% Purity Type
99% Purity Type
Others
Global Acemetacin (CAS 53164-05-9) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Acemetacin (CAS 53164-05-9) Market Segment Percentages, by Application, 2021 (%)
Asimicin Capsule (30mg)
Asimexin Sustained Release Capsule (90mg)
Global Acemetacin (CAS 53164-05-9) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Acemetacin (CAS 53164-05-9) Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Acemetacin (CAS 53164-05-9) revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Acemetacin (CAS 53164-05-9) revenues share in global market, 2021 (%)
Key companies Acemetacin (CAS 53164-05-9) sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Acemetacin (CAS 53164-05-9) sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
3B Scientific
CSPC
DC Chemicals
OChem
Adooq BioScience
Clearsynth
Angene Chemical
Vlada Chem
AbMole Bioscience
MuseChem
AHH Chemical
Jiangmin Taihua Chemical
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy